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Cytokines are inﬂammatory messengers that orchestrate the brain’s response to immuno-
logical challenges, as well as possibly even toxic and psychological insults. We previously
reported that genetic ablation of the pro-inﬂammatory cytokine, interferon-gamma (IFN-
γ), attenuated some of the corticosteroid, cytokine, and limbic dopaminergic variations
induced by 6 weeks of exposure to an unpredictable psychologically relevant stressor.
Presently, we sought to determine whether a lack of IFN-γ would likewise modify
the impact of chronic stress on hippocampus-dependent memory function and related
neurotransmitter and neurotrophin signaling systems. As predicted, chronic stress impaired
spatial recognition memory (Y-maze task) in the wild-type animals. In contrast, though the
IFN-γ knockouts (KOs) showed memory disturbances in the basal state, under conditions
of chronic stress these mice actually exhibited facilitated memory performance. Paralleling
these ﬁndings, while overall the KOs displayed altered noradrenergic and/or serotonergic
activity in the hippocampus and locus coeruleus, norepinephrine utilization in both of these
memory-related brain regions was selectively increased among the chronically stressed
KOs. However, contrary to our expectations, neither IFN-γ deletion nor chronic stressor
exposure signiﬁcantly affected nucleus accumbens dopaminergic neurotransmission or
hippocampal brain-derived neurotrophic factor protein expression. These ﬁndings add to
a growing body of evidence implicating cytokines in the often differential regulation of
neurobehavioral processes in health and disease.Whereas in the basal state IFN-γ appears
to be involved in sustaining memory function and the activity of related brain monoamine
systems, in the face of ongoing psychologically relevant stress the cytokine may, in fact,
act to restrict potentially adaptive central noradrenergic and spatial memory responses.
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INTRODUCTION
It is widely accepted that the likelihood of developing depres-
sion, anxiety, and other psychological disorders is greatly inﬂu-
enced by exposure to stressors, particularly those of a chronic,
unpredictable, and/or psychosocial nature (Hill et al., 2012).
The prevailing view over many years has been that stressor-
induced alterations of brain monoamine activity were largely
responsible for the emotional and cognitive symptoms seen
to predominate in these conditions (Schildkraut, 1965). While
evidence continues to implicate monoaminergic neurotransmit-
ter processes (Fava, 2003; Hamon and Blier, 2013), deﬁcits in
trophic growth factors such as brain-derived neurotrophic fac-
tor (BDNF), and even structural brain changes (e.g., impaired
neurogenesis) have emerged as important players too in this
regard (Pittenger and Duman, 2008; Calabrese et al., 2009;
Mahar et al., 2014).
It’s become increasingly clear that cytokines and other elements
of the inﬂammatory immune system contribute importantly to
depression and other stress-related psychological disturbances
(Miller et al., 2009; Anisman and Hayley, 2012). For instance,
numerous studies have reported that pro-inﬂammatory cytokines,
most notably interleukin-1-beta (IL-1β), IL-6, interferon-alpha
(IFN-α), and tumor necrosis factor-alpha (TNF-α), are altered
in major depression and stressor-based animal models (Dowlati
et al., 2010; Liu et al., 2012; Dahl et al., 2014). Moreover,
administration of these cytokines to rodents induced behav-
ioral, hormonal, monoamine, and neuroplastic changes that
are reminiscent of at least some depressive-like clinical changes
(Myint et al., 2007; Anisman et al., 2008; Kaster et al., 2012;
Sukoff Rizzo et al., 2012). The fact that anti-inﬂammatory and
anti-cytokine treatments (e.g., minocycline, curcumin, cytokine-
speciﬁc antagonists) were reported to lessen the neural and
behavioral impact of stressor exposure further supports a link
between cytokines and stressor pathology (Koo and Duman,
2008; Hinwood et al., 2012; Jiang et al., 2013; Krügel et al.,
2013).
Interferon-gamma (IFN-γ), which is a crucial mediator of
both innate and adaptive immune responses, is another cytokine
that has recently been posited to play a role in stressor-related
psychological pathology. Several studies have reported elevated
circulating levels of IFN-γ among depressed patients (Simon
et al., 2008; Gabbay et al., 2009; Dahl et al., 2014; Schmidt
et al., 2014), and many of the most commonly used antide-
pressants were found to antagonize IFN-γ signaling (Maes
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et al., 1999; Kubera et al., 2001; Brustolim et al., 2006). More-
over, variation in the IFN-γ gene was recently reported to
modify both depression risk (in the context of IFN-α treat-
ment; Oxenkrug et al., 2011) and antidepressant medication
effectiveness (Myint et al., 2013). Consistent with these ﬁnd-
ings, Kwant and Sakic (2004) reported that mice infected with
IFN-γ adenovector displayedpersistent anhedonic-like symptoms,
and O’Connor et al. (2009a,b) showed that IFN-γ is a major
driver of the indoleamine 2,3-dioxygenase (IDO)-enhancing and
depressive-like behavioral effects of the immune-activating agents,
lipopolysaccharide (LPS) and Bacillus Calmette–Guerin. Yet,
compared with many of the other cytokines that have been
linked to depressive illness, far fewer studies have actually set
out to speciﬁcally test the inﬂuence of endogenous IFN-γ in
ecologically inspired chronic stressor animal models; this is espe-
cially true in regards to the cognitive aspects of depressive-like
pathology.
As one of the most potent activators of microglial cells
and key regulator of the anti-viral response (Chesler and Reiss,
2002), IFN-γ is likely to be especially important for condi-
tions in which infection overlaps with stressor exposure or in
genetically vulnerable individuals (Litteljohn et al., 2010). In
this regard, we previously found that IFN-γ-deﬁcient mice had
attenuated hormonal, cytokine and brain regional dopaminergic
responses to chronic stress, despite showing several conspicu-
ous behavioral and physiological differences in the basal state
(i.e., increased anxiety-like behavior, elevated circulating corti-
costerone levels and central amygdala monoamine utilization;
Litteljohn et al., 2010). This complex pattern of effects led us
to theorize that IFN-γ contributes to a range of affective and
perhaps cognitive processes, albeit probably in very different
ways and to markedly different ends under basal and chronic
stress conditions. Working under this theoretical framework, in
the present investigation we sought to assess the largely unex-
plored role of IFN-γ in the spatial memory, psychomotor, and
hippocampal BDNF and monoamine changes that are often evi-
dent following protracted exposure to psychologically relevant
stressors.
MATERIALS AND METHODS
EXPERIMENTAL ANIMALS
Establishment of the IFN-γ –/– knockout (KO) mouse, which
develops normally and is healthy in the absence of pathogenic
challenge, has been described previously (Dalton et al., 1993).
IFN-γ KO and wild-type (WT; IFN-γ +/+) mice raised on a
C57BL/6J genetic background were obtained from The Jack-
son Laboratory (Bar Harbor, ME, USA) and interbred for
several generations. At 6–7 weeks of age, KO and WT litter-
mate controls from our breeding colony were singly housed
in standard polycarbonate cages (27 cm × 21 cm × 14 cm).
Animals were maintained on a 24 h light/dark cycle with
lights on at 08:00. A diet of Ralston Purina (St. Louis,
MO, USA) mouse chow and water was provided ad libi-
tum, and room temperature was maintained at ∼21◦C.
All experimental procedures were approved by the Carleton
University Committee for Animal Care and complied with
the guidelines set out by the Canadian Council for the
Use and Care of Animals in Research. The animals were
between 10 and 12 weeks of age upon commencement of the
study.
FIGURE 1 | Schematic showing the experimental design and timeline.
IFN-γ knockout (KO) and wild-type (WT) littermate mice (n = 46 per
genotype) were randomly assigned to a 6-week chronic stressor
condition or a non-stress control group (n = 23; A). Mice of each
condition were further divided into behavioral testing (n = 10; B) and
behaviorally naïve cohorts (n = 13; C), the latter of which were used for
end-of-study brain regional monoamine (n = 10) or hippocampal BDNF
analyses (n = 3).
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CHRONIC STRESSOR REGIMEN
Figure 1presents a schematic of the experimental design and time-
line. Animals of either genotype (n = 46) were randomly assigned
to a 6-week chronic stressor condition or a non-stress control
group (n = 23). Mice of each condition were further divided
into behavioral testing (n = 10) and behaviorally naïve cohorts
(n = 13), the latter of which were used for end-of-study brain
regional monoamine (n = 10) or hippocampal BDNF analyses
(n = 3). The chronic stressor regimen comprised the applica-
tion of two stressors per day (or a single stressor on behavioral
testing days) on a variable and unpredictable schedule, and con-
sisted of both mild and moderate stressors per the method and
rationale of Litteljohn et al. (2010). A list of the various stres-
sors used is provided in Table 1. Following the ﬁrst (morning)
stressor, mice were returned to their home-cage until applica-
tion of the second (afternoon) stressor. Animals assigned to
the chronic stressor condition were housed in a holding room
separate from, but otherwise identical to, their non-stressed
counterparts.
BEHAVIORAL ASSESSMENTS
Spontaneous home-cage activity
Measurements of horizontal motor activity were obtained during
complete, uninterrupted 12 h light/dark cycles using a Micromax
infrared beam-break apparatus (AccuScan Instruments, Colum-
bus, OH, USA) exterior to the home-cage. The same animals were
tested on two separate occasions, corresponding to the midway
point (Week 3: Day 21) and endpoint (Week 6: Day 42) of the
stressor paradigm, and the data analyzed using a repeated mea-
sures analysis of variance (ANOVA). Testing commenced 60 min
after termination of the morning stressor.
Spatial memory in the two-trial Y-maze
During the ﬁnal week of the experiment (Day 40), intermediate-
term spatial recognition memory was assessed in a two-trial
Y-maze task, in accordance with previously published methods
(Dellu et al., 2000; Ferguson et al., 2000). The testing appara-
tus comprised three arms (30 cm × 8 cm × 15 cm) fashioned
from black Plexiglas with an outer wood shell. The testing
room was dimly lit and had on its walls various cardboard
cut-outs of basic geometric shapes. During the ﬁrst trial (acqui-
sition phase) one arm of the maze was blocked with an opaque,
removable panel. Mice were then placed individually in one of
the two remaining accessible arms (i.e., the ‘start’ arm, which
remained so in the second trial), with head directed away from
the center of the maze. Animals were allowed to explore the
open arms of the Y-maze for 5 min, after which they were
returned to the home-cage. After 30 min, the second trial
(retrieval phase) was conducted under identical experimental
conditions to the ﬁrst, excepting that the mice were now per-
mitted free exploration for 5 min of all three arms of the
maze (start, familiar and novel). The blocked arm (i.e., novel
arm in the retrieval phase) varied between mice in a prede-
termined, pseudo-random manner, and the maze was cleaned
with a dilute (2%) ethanol solution after each trial. Total arm
entries (for each trial, deﬁned as all four legs having entered
a given arm) and % duration in the novel, start and familiar
arms (Trial 2) were determined for each mouse. A discrimina-
tion index (DI) for novelty was calculated as follows: novel arm
duration − (start arm duration + familiar arm duration)/2. A
DI value not signiﬁcantly different than zero (0) is understood
to reﬂect a deﬁcit in novelty discrimination (e.g., see Leconte
et al., 2011). Y-maze testing occurred between 09:00 and 13:00
Table 1 | List of stressors.
Stressor Duration Specifications
Social interaction 60 min Placement in a large cage (40 cm × 25 cm × 15 cm) divided into separate quadrants with three
non-experimental male C57BL/6J mice (3–6 months old); this set-up allowed for interactions but not ﬁghting
Soiled cage 60 min Introduction into a congener’s soiled cage
Fox urine 5 min Exposure to 250 cc fox urine-infested air (Foxpert, St. Benjamin, QC, Canada) while in a novel, empty cage
Rat feces 60 min Introduction into an unfamiliar cage with fresh rat feces
Flat bottom restraint 15 min Restraint in semicircular Plexiglas tubes (4 cm × 12 cm) with tails taped to prevent mice from turning
Plastic bag restraint 15 min Restraint in tight-ﬁtting triangular plastic bags equipped with a nose-hole for breathing
Footshock — 15 shocks, 500 ms duration at 30 s intervals, 0.3 mA, 60 Hz, a.c.) administered in individual shock chambers
(30 cm × 14 cm × 15 cm)
Injection/handling — Intraperitoneal injection of 0.2 ml sterile physiological saline (Sigma Aldrich, USA)
Damp bedding 60 min 60 ml of water/l of sawdust bedding in novel cage
Tail hang 30 s —
Empty cage 60 min Introduction into an empty cage without sawdust or nestlet
Noise 10 min Intermittent background noise (40 dB) in isolated restraint chambers (30 cm × 14 cm × 15 cm)
Cage tilt 60 min 30◦ tilt of home-cage
Forced swim 3 min Forced swim in a glass cylinder (20 cm diameter × 25 cm high) containing tepid water (22 ± 1◦C, 15 cm deep)
Light/dark cycle disruption 12 h Lights on during dark phase
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(i.e., 17–21 h after the previous day’s afternoon stressor), after
which mice in the stressor groups received a single afternoon
stressor.
BRAIN DISSECTION METHOD
Animals were rapidly decapitated between 09:00 and 11:00 on
the day following the completion of the 6-week chronic stressor
regimen (i.e., 17–19 h after the ﬁnal stressor treatment, which
for all animals was a 15-min ﬂat-bottom restraint). Brains were
excised and sectioned into sequential coronal slices using razor
blades and a chilled stainless steel microdissecting block with adja-
cent slots arranged 0.5 mm apart. The locus coeruleus and nucleus
accumbens were obtained by micropunch using a hollow 1.0 mm
diameter biopsy needle (collected bilaterally), whereas the dor-
sal hippocampus was microdissected in its entirety using chilled
razor blades. Brain tissue samples were taken with reference to
the mouse brain atlas of Franklin and Paxinos (1997). A sub-
set of the hippocampal samples was ﬂash-frozen and stored at
−80◦C for later determination of BDNF content by Western blot
(n = 3). The remaining samples were maintained in a homogeniz-
ing solution containing 14.17 g monochloroacetic acid, 0.0186 g
EDTA,5.0mlmethanol, and 500ml high performance liquid chro-
matography (HPLC) grade water; and stored at −80◦C for HPLC
analysis.
HPLC DETERMINATION OF CENTRAL AMINE AND METABOLITE
CONCENTRATIONS
Levels of norepinephrine (NE), serotonin (5-HT) and dopamine
(DA), and their respective primary metabolites, 3-methoxy-
4-hydroxyphenylglycol (MHPG), 5-hydroxyindole acetic acid
(5-HIAA), and 3,4-dihydroxyphenylacetic acid (DOPAC) and
homovanillic acid (HVA), were determined by HPLC within
relevant brain punches according to previously reported meth-
ods (Liu et al., 2014). Tissue punches were homogenized by
ultrasonic disruption (Sonic Dismembrator Model 100, Fisher
Scientiﬁc) in the homogenizing solution in which they were
initially frozen (with DHBA as an internal standard). The
level of protein was determined with the Pierce BCA Pro-
tein Assay Kit (Thermo Scientiﬁc 23225). Homogenized sam-
ples were centrifuged (12000 rpm for 3 min at 4◦C), after
which 50 μl of supernatant was injected, at a ﬂow rate of
1 ml/min, into the automated HPLC system (Agilent 1100)
with electrochemical detector (DECADE II SDC, Antec) and
ZORBAX Eclipse XDB-C8 columns (Agilent: 4.6 mm inner
diameter, 150 mm length, 5 μm particle size; thermostated
at 40◦C); the oxidation potential was maintained at 0.60 V.
The mobile phase comprised: 90 mM sodium phosphate
monobasic, 1.7 mM 1-octanesulfonic acid, 50 mM EDTA,
10% acetonitrile, 50 mM citric acid (monohydrate), 5 mM
KCL, and HPLC-grade water. Monoamine and metabolite
concentrations were expressed relative to the protein content
of the samples, and ﬁnal results presented as ng/mg pro-
tein.
HIPPOCAMPAL BDNF PROTEIN DETERMINATION
Western immunoblotting was performed largely in accordance
with our previously published methods (Mangano et al., 2011).
Brieﬂy, brain tissues (n= 3)were homogenized on ice in RIPA lysis
buffer containing 50 mM Tris-base (pH 8.0), 150 mM NaCl, 1%
Triton-X, 0.1% SDS, 0.5% sodium deoxycholate, and cOmplete
Mini EDTA-free protease inhibitor (Roche, Basel, Switzerland).
Lysates were centrifuged for 5 min (5000 rpm at 4◦C) and super-
natants collected. Total protein was then determined using a
BCA Protein Assay kit (Thermo Fisher Scientiﬁc, Waltham, MA,
USA). Protein from the hippocampus (50 μg/well) was diluted
to a ﬁnal volume of 35 μl in RIPA lysis buffer and 1X load-
ing buffer (5% glycerol, 5% β-mercaptoethanol, 3% SDS, and
0.05% bromophenol blue), and samples heated in boiling water
for 5 min. Proteins were separated by electrophoresis (120 V) on
12.5%sodiumdodecyl sulfate-polyacrylamide gels and transferred
overnight at 4◦C (180 mA) onto PVDF membranes (Bio-Rad,
Hercules, CA, USA). Membranes were then blocked for 1-h with
gentle agitation at room temperature in a Tris-buffered saline
[TBS-T: 10 mM Tris-base (pH 8.0), 150 mM NaCl, 0.5% Tween-
20] solution containing non-fat dry milk (5% w/v). Anti-BDNF
primary antibody (1:500, sc-546, Santa Cruz Biotechnology, Dal-
las, TX, USA) was applied for 1.5-h at room temperature. After
four successive 10-min washes in TBS-T, membranes were incu-
bated with secondary antibody for 1-h at room temperature and
with gentle shaking (goat anti-rabbit IgG peroxidase, 1:1000,
A6154, Sigma). After another series of TBS-T washes, bands
were visualized by exposing Kodak X-OMAT ﬁlm (10 min for
BDNF, 10 s for β-actin) to membranes treated with ECL sub-
strate (Perkin Elmer, Waltham, MA, USA; for 1 min). The
immunoblots were imaged using aKonicaMinolta SRX-101Apro-
cessor (Konica Minolta, Marunouchi, Chiyoda-ku, Tokyo), and
band density quantiﬁed using AlphaEaseFC v.3.1.2 densitometry
software (Alpha Innotech, San Leandro, CA, USA). After nor-
malizing against β-actin (anti-β-actin; 1:5000, sc-47778, Santa
Cruz), the BDNF/actin ratios were averaged across blots and
the standard error of the mean determined for each treatment
group.
STATISTICAL ANALYSES
The monoamine and Western immunoblot data were analyzed by
2 (Genotype; WT vs. IFN-γ KO) × 2 (Treatment; non-stressed
vs. stressed) ANOVAs followed where appropriate by Student–
Newman–Keuls pairwise multiple comparisons (p < 0.05). The
home-cage activity data were analyzed by a repeated measures
ANOVA with Genotype and Treatment as the between-subjects
variables and Time (Week 3 vs. Week 6) as the repeated measures
variable. A mixed model ANOVA was also used for analyzing %
duration in the three arms of the Y-maze; here, Genotype and
Treatment were the between-subjects variables and Arm (novel
vs. start vs. other) served as the within-subjects variable. Planned
univariate t-tests facilitated comparisons of spatial memory per-
formance in each of the experimental groups (% novel arm
duration, DI) with that of a theoretical group performing at
chance-level (33.33% and 0, respectively). In addition, Spearman’s
rank-order correlation coefﬁcients (ρ) were calculated to assess
the degree of association between locomotion (total arm entries)
and memory performance (DI) in the Y-maze; separate analyses
were conducted for the total sample (collapsing across IFN-γ KO
and stress) and each of the four treatment groups. On account
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of procedural error, one mouse was excluded from the home-
cage activity assessments and two mice excluded from the Y-maze
analyses. During the course of tissue dissection and monoamine
determination a few samples were lost due to error or variability
(>2.5 standard deviation from the mean); hence, the degrees of
freedom for the statistical analyses varied within and across some
brain regions and/or neurochemical substrates. Data were evalu-
ated using a StatView (version 6.0) statistical software package and
plotted with GraphPad Prism 6 (La Jolla, CA, USA).
RESULTS
CHRONIC STRESSOR TREATMENT TIME-DEPENDENTLY INFLUENCED
HOME-CAGE ACTIVITY IN IFN-γWILD-TYPE AND KNOCKOUT MICE
It is understood that psychologically relevant stressors can modu-
late motor functioning, and sometimes in diametrically opposed
ways (Soblosky and Thurmond, 1986; Venzala et al., 2012).
Indeed, psychomotor symptoms are a quite common occurrence
in depression, as well as myriad other stressor-related psychi-
atric conditions (Buyukdura et al., 2011). Here, we report the
outcomes of our time series analysis of home-cage locomo-
tor activity. The repeated measures ANOVA revealed signiﬁcant
Genotype × Treatment and Treatment × Time interactions
for home-cage activity (Fs1,35 = 5.27 and 14.66, respectively,
p < 0.05). As shown in Figure 2, while at the midway point of
the experiment (Week 3) motor activity was signiﬁcantly reduced
by the chronic stressor, by the end of the experiment (Week
6) animals that were exposed to the stressor actually displayed
increased home-cage activity (p < 0.05). Despite ﬁnding a signif-
icant Genotype × Treatment interaction for home-cage activity,
follow-up analyses failed to reveal any statistically signiﬁcant sim-
ple main effects. The existence of such a “crossover” interaction
suggests that the early occurring, hypolocomotive effect of the
FIGURE 2 | Influence of chronic stress on home-cage locomotor
activity among IFN-γ wild-type and knockout mice. Overall, chronic
stressor exposure had the effect of reducing home-cage activity at Week 3
(mid-way through the experiment), but increasing locomotor activity at
Week 6 (end of experiment). However, the early occurring hypolocomotive
effect of stress was clearly most prominent in the WT animals, whereas
the stressor’s later-occurring hyperlocomotive effect was most evident in
the KO mice (see accompanying text). Data are presented as mean ± SEM.
*p < 0.05 relative to non-stressed mice (collapsed across genotype) at
Week 3, and ˆp < 0.05 relative to non-stressed mice (collapsed across
genotype) at Week 6 (Two-way repeated measures ANOVA). WT, wild-type;
KO, knockout.
chronic stressor predominated in the WT animals, whereas the
later-occurring, activity-boosting effect of the stressor was most
pronounced in the KOs; this interpretation is borne out by visual
inspection of the data (see Figure 2). Moreover, the multiple
Bonferroni-corrected pairwise comparisons revealed that, atWeek
6, only the stressed IFN-γ KO mice displayed signiﬁcantly higher
levels of activity compared to their non-stressed counterparts
(p < 0.0018).
CHRONIC STRESS FACILITATED SPATIAL RECOGNITION MEMORY IN
THE IFN-γ KNOCKOUT MICE
Table 2 presents the total number of arm entries during the
acquisition (Trial 1) and retention phases (Trial 2) of the Y-maze
test. During the acquisition phase, the IFN-γ KOs made fewer
total arm entries than the WT animals, regardless of stres-
sor treatment (F1,34 = 9.05, p < 0.01). In contrast, during
the retention phase the total number of arm entries did not
differ signiﬁcantly between groups (Fs < 2.8, see Table 2).
Since the acquisition phase of the Y-maze task is compara-
tively anxiety-laden, it is not surprising that the IFN-γ KOs,
for which we and others have previously described an anx-
ious phenotype (Kustova et al., 1998; Litteljohn et al., 2010;
Campos et al., 2014), should display reduced activity in this
context.
Time spent exploring the novel arm of the Y-maze is consid-
ered a reliable index of spatial memory functioning in rodents
(Dellu et al., 2000; Leconte et al., 2011). The initial mixed model
ANOVA revealed a signiﬁcant main effect of Arm (F2,68 = 6.88,
p < 0.01), such that overall the mice spent signiﬁcantly more
time exploring the novel vs. start or familiar arms (p < 0.05).
Yet, as shown in Figure 3A and conﬁrmed by the planned
univariate t-tests, of the four treatment groups, only the non-
stressed WT controls and the chronically stressed IFN-γ KO mice
performed signiﬁcantly above chance-level (33.33%, p < 0.05).
Equivalently, our analysis of DI scores revealed that whereas
both the WT control and stressed KO animals discriminated
the novel arm to a signiﬁcant extent (DI scores greater than 0,
p < 0.05, see Figure 3B), neither the non-stressed IFN-γ KO
controls nor the chronically stressed WT mice had DI values
signiﬁcantly different than 0 (p > 0.1). However, the corre-
sponding ANOVA failed to uncover any statistically signiﬁcant
between-group differences (Fs < 3.75), and the within-group
Table 2 |Total number of arm entries during theY-maze acquisition and
retention phases.
Treatment condition
WT-No stress WT-stress KO-no stress KO-stress
Acquisition
phase
27.4 ± 1.1 25.1 ± 2.5 21.1 ± 1.4* 20.7 ± 1.5*
Retention
phase
25.1 ± 1.8 20.1 ± 1.6 21.1 ± 1.7 20.6 ± 1.5
Data are presented as mean ± SEM (n = 8–10). *p < 0.05 relative to wild-type
mice (collapsed across the stressor treatment). WT, wild-type; KO, knockout.
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FIGURE 3 | Impact of IFN-γ deletion on short-term spatial memory
function under basal vs. chronic stressor conditions. As regards both
the percentage (%) time spent exploring the novel arm of the Y-maze
(A) and the novelty discrimination index (DI; B), of the four treatment
groups, only the non-stressed wild-type controls and the chronically
stressed IFN-γ knockout mice performed at a level signiﬁcantly above
chance (33.3% and 0, respectively). While overall there was no
association between DI scores and total Y-maze arm entries (C), when
the correlation analysis was restricted to the chronically stressed
knockouts, Y-maze locomotion tended to correlate negatively with spatial
memory performance (D; see accompanying text). Data are presented as
mean ± SEM; horizontal dashed lines represent chance-level performance
(33.3% or 0), the solid line represents the best ﬁt linear regression line,
and the curved dashed lines show the 95% conﬁdence interval.
*p < 0.05 relative to chance (univariate t -test). WT, wild-type; KO,
knockout.
variability of DI scores was clearly quite considerable (see
Figure 3B).
In view of the stressor-induced and genotype-speciﬁc changes
in home-cage activity, and despite the lack of signiﬁcant treat-
ment effects on total arm entries in the retention phase of the
Y-maze, it was of interest to determine whether Y-maze locomo-
tion correlated with spatial memory performance. In this regard,
there was an utter lack of association between DI scores and total
Y-maze arm entries when collapsing across the treatment groups
(ρ = –0.05, p > 0.70, see Figure 3C). This was similarly the case
when separate analyses were performed for the WT control, WT
stressed and IFN-γ KO control groups (ρ = 0.43, 0.14, −0.14,
respectively, p > 0.25). Yet, in the case of the chronically stressed
KOs, though the negative correlation between DI scores and Y-
maze activity was not statistically signiﬁcant at the α = 0.05 level
(ρ = −0.60, p = 0.07), the p value was considerably less than
0.10. While acknowledging the need for caution in interpreting
this marginally signiﬁcant trend, as seen in Figure 3D it would
appear that, in the chronically stressed KOs only, reduced Y-maze
locomotion tended to correspond with better spatial memory
performance.
BRAIN REGIONAL MONOAMINERGIC EFFECTS OF CHRONIC STRESS
AND IFN-γ KNOCKOUT
Within the dorsal hippocampus, neither chronic stress nor IFN-γ
deletion signiﬁcantly affected the levels of 5-HT or its primary
metabolite, 5-HIAA (Fs < 2.7; see Figures 4A,B). However, as
shown in Figure 4C, 5-HT turnover (i.e., the ratio of metabo-
lite to parent amine) was signiﬁcantly diminished overall among
mice genetically lacking IFN-γ (F1,34 = 5.75, p < 0.05). A
separate ANOVA revealed that the KOs also had diminished
hippocampal NE levels relative to the WT mice, regardless of
stressor history (F1,33 = 7.15, p < 0.05; see Figure 4D). In
addition, concentrations of the primary NE metabolite, MHPG,
varied according to the signiﬁcant interaction of Genotype with
Stress (F1,33 = 5.05, p < 0.05). As shown in Figure 4E and
conﬁrmed by the post hoc comparisons, whereas chronic stress
had no effect on hippocampal MHPG levels in the WT ani-
mals, accumulation of the metabolite was robustly enhanced in
the stressed KOs (p < 0.05, relative to KO controls). A sig-
niﬁcant Genotype × Stress interaction was likewise uncovered
for NE turnover (F1,32 = 6.24, p < 0.05) such that the ratio
of hippocampal MHPG to NE was markedly elevated in the
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FIGURE 4 | Hippocampal serotonin and noradrenergic activity as a
function of IFN-γ knockout and chronic stressor exposure.Within the
hippocampus, neither 5-HT (A) nor 5-HIAA (B) was signiﬁcantly affected by
chronic stress or IFN-γ deletion. Yet, 5-HT turnover (i.e., the ratio of 5-HIAA
to 5-HT; C) was diminished overall in the IFN-γ knockouts compared to the
wild-type mice. With respect to noradrenergic neurotransmission in the
hippocampus, NE levels (D) were signiﬁcantly reduced among the IFN-γ
knockout mice, irrespective of chronic stress. In contrast, both MHPG
accumulation (E) and NE turnover (MHPG-to-NE ratio; F) were signiﬁcantly
enhanced following chronic stress, but only among the IFN-γ knockouts.
Data are presented as mean ± SEM; *p < 0.05 (Two-way ANOVA followed
by Student–Newman–Keuls test). WT, wild-type, KO, knockout.
stressed IFN-γ KOs compared to all other groups (p < 0.05; see
Figure 4F).
Within the locus coeruleus, NE concentrations were sig-
niﬁcantly higher in the IFN-γ-deﬁcient animals compared to
their WT littermates, irrespective of chronic stressor exposure
(F1,35 = 8.48, p < 0.01; see Figure 5A). But akin to what
was observed in the hippocampus, locus coeruleus MHPG lev-
els varied as a function of the interaction between Genotype
and Stress (F1,34 = 6.18, p < 0.05). As depicted in Figure 5B
and conﬁrmed by the follow-up tests, among the IFN-γ KOs
chronic stress induced a marked rise in MHPG concentra-
tions (p < 0.05 compared to all other groups). In WT mice,
however, MHPG levels were completely unaffected by the stressor.
Notwithstanding these changes, the ANOVA for locus coeruleus
NE turnover did not reveal any signiﬁcant main or interac-
tion effects of IFN-γ deletion and chronic stress (Fs < 1.4; see
Figure 5C).
Dopaminergic gating of information through the stressor-
sensitive nucleus accumbens is considered to play an important
role in bothmotor andmemory function (Costall et al., 1984; Mele
et al., 2004; Baker and Kalivas, 2005). It was therefore of interest
in the present study to characterize the accumbal dopaminergic
effects of chronic stress and IFN-γ deﬁciency. As shown in Table 3,
neither of the experimental treatments (nor their interaction) sig-
niﬁcantly affected indices of dopaminergic neurotransmission in
this brain region (DA, DOPAC, and HVA concentrations, as well
as DA turnover; Fs< 3.4).
HIPPOCAMPAL BDNF EXPRESSION WAS UNCHANGED FOLLOWING
CHRONIC STRESSOR EXPOSURE
A large body of evidence demonstrates that the neurotrophic
factor, BDNF, is essential for hippocampus-dependent memory
function and adaptive neuroplastic responses to stressors (Schmidt
andDuman,2010; Taliaz et al., 2010).Wewere therefore somewhat
surprised to ﬁnd that neither chronic stress nor IFN-γ deletion
signiﬁcantly inﬂuenced hippocampal BDNF protein expression
(Fs < 1, see Figures 6A,B). The Western immunoblot analysis
likewise failed to reveal any signiﬁcant main or interaction effects
of the experimental treatments on the hippocampal protein con-
centrations of a neuronally secreted immature form of BDNF (i.e.,
proBDNF; Fs< 1, see Figures 6A,C).
DISCUSSION
Accumulating evidence suggests a role of IFN-γ in depression and
other stressor-associated psychological disturbances (O’Connor
et al., 2009a; Dahl et al., 2014); however, the question whether
IFN-γ contributes to the pathological process in ecologically
inspired chronic stressormodels has gone largely untested. Inwhat
is to the best of our knowledge the only other study published
to date on this subject, we previously reported that IFN-γ deﬁ-
ciency conferred protection in mice against some of the immune,
stress hormone and limbic monoamine effects associated with
chronic exposure to a psychologically relevant stressor (Litteljohn
et al., 2010). Intriguingly, our results also suggested that IFN-γ
may have divergent emotion-relevant actions under normal and
chronic stressor conditions, as the KO animals basally showed
enhanced anxiety-like behavior coupled with heightened corti-
costeroid levels and central amygdala NE and 5-HT usage. Such
ﬁndings are actually consistent with the earlier results of Kus-
tova et al. (1998), as well as the more recent ones of Campos
et al. (2014), which indicated that mice genetically lacking IFN-γ
are characterized basally by increased emotionality and anxiety.
The results of the present investigation extend these ﬁndings
by demonstrating that stressor context also appears to be cru-
cial in determining the inﬂuence of IFN-γ on spatial memory
function and related neurochemical systems. Indeed, under nor-
mal conditions mice genetically lacking IFN-γ exhibited impaired
spatial memory, which we suggest might be related to altered
hippocampal (and perhaps locus coeruleus) monoaminergic
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FIGURE 5 | Locus coeruleus noradrenergic activity as a function of IFN-γ
knockout and chronic stressor exposure. Compared to the wild-type
animals, concentrations of locus coeruleus NE (A) were signiﬁcantly higher
among the IFN-γ-deﬁcient mice, regardless of stressor exposure. As regards
MHPG in this brain region (B), whereas metabolite levels were unaffected by
chronic stress in the wild-type mice, among the stressed IFN-γ knockouts
MHPG accumulation was signiﬁcantly enhanced. The experimental
manipulations did not, however, signiﬁcantly alter locus coeruleus NE
turnover (ratio of MHPG-to-NE; C). Data are presented as mean ± SEM;
*p < 0.05 (Two-way ANOVA followed by Student–Newman–Keuls test).
Table 3 | Dopaminergic activity within the nucleus accumbens as a function of chronic stress and IFN-γ deletion.
Concentration (ng/mg protein) DA turnover
[(DOPAC+HVA)/DA]
DA DOPAC HVA
WT-no stress 123.57 ± 14.76 15.43 ± 1.19 7.95 ± .43 0.216 ± 0.035
WT-stress 152.78 ± 17.56 15.98 ± 1.04 5.96 ± .91 0.173 ± 0.039
KO-no stress 156.33 ± 20.07 16.81 ± 1.36 5.50 ± .54 0.155 ± 0.017
KO-stress 186.87 ± 19.00 17.67 ± 1.61 6.28 ± .85 0.145 ± 0.022
Data are presented as mean ± SEM. DA, dopamine; DOPAC, 3,4-dihydroxyphenylacetic acid; HVA, homovanillic acid.
neurotransmission but not BDNF signaling or nucleus accum-
bens dopaminergic activity. Contrastingly, under conditions
of chronic stress IFN-γ deﬁciency appeared actually to facili-
tate memory function, and this pro-mnemonic effect coincided
with enhanced hippocampal and locus coeruleus noradrenergic
activity.
IMPACT OF IFN-γ DEFICIENCY ON MEMORY AND RELATED BRAIN
PROCESSES UNDER NORMAL CONDITIONS
It is now well recognized that pro-inﬂammatory cytokines
can modulate cognitive processes, with pathological conse-
quences probably at the forefront of attention. Yet, there is
increasing evidence to suggest that cytokines and other pro-
inﬂammatory stimuli (e.g., prostaglandins, amyloid-β peptide:
Cowley et al., 2008; Puzzo et al., 2012) may under certain
circumstances actually be beneﬁcial for learning and mem-
ory; the key determinant here appears to be cytokine level
(McAfoose and Baune, 2009; Yirmiya and Goshen, 2011). While
highly elevated concentrations of pro-inﬂammatory cytokines,
as can occur for instance in depression and many of its
comorbid conditions (Anisman and Hayley, 2012; Dahl et al.,
2014), generally provoke anti-mnemonic effects, it would appear
that a certain basal physiological level of pro-inﬂammatory
cytokine signal is required for normal memory function (Yir-
miya and Goshen, 2011). Evidencing the latter, mice genet-
ically lacking TNF-α or TNF receptor 1 displayed impaired
spatial memory (TNF-R2 KO mice, however, displayed intact
memory; Camara et al., 2013), and IL-1β signaling block-
ade produced a similar functional effect (Yirmiya et al., 2002;
Goshen et al., 2007).
Consistent with such a view, we presently report that mice
lacking IFN-γ showed disturbed spatial recognition memory in
the basal state. Interestingly, Baron et al. (2008) revealed that
limited central overexpression of IFN-γ resulted in improved
hippocampus-dependent memory, whereas pathologically ele-
vated concentrations of the cytokine have generally been asso-
ciated with memory impairment (Lapter et al., 2009; Dutra et al.,
2013; Too et al., 2014). Thus, when considered together, these
data suggest that the hormetic-like dose-response pattern that was
described elsewhere for memory and IL-1β (and several other
immune actors; Yirmiya and Goshen, 2011) may very well be
relevant too for IFN-γ. Further investigation is warranted to sub-
stantiate this possibility, and such efforts will do well to include
a detailed time-and-dose-response analysis, as well as determina-
tions of both circulating and brain regional IFN-γ concentrations
in ecologically relevant animal disease models. Also, some cau-
tion should be exercised when interpreting the Y-maze behavioral
data in the present study: while basally the KOs failed to per-
form signiﬁcantly better than chance (consistent with impaired
spatial memory), the ANOVA test did not reveal any signiﬁ-
cant between-group differences. As mentioned previously, there
was considerable within-group variability in the behavioral data,
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FIGURE 6 | Influence of chronic stress and IFN-γ knockout on BDNF
protein expression within the hippocampus. Representative
immunoblots (A) were cropped and adjusted for brightness and contrast
using Fotor photo editor software (version 1.3.1). Neither chronic stress nor
IFN-γ knockout signiﬁcantly affected mature BDNF (B) or proBDNF (C)
protein expression within the hippocampus. Actin-normalized integrated
density values (IDVs) are presented as mean ± SEM (n = 3).
and this likely reﬂects the critical but often overlooked inﬂu-
ence of individual differences in chronic stress susceptibility (e.g.,
Bergström et al., 2008). Therefore, it is our suggestion that the
present ﬁndings be viewed as proof-of-principle formore compre-
hensive and larger-scale investigation into the prospective learning
and memory effects of IFN-γ.
With respect to the possible neural substrate(s) subserving
these memory changes, we submit that it may be particularly
telling that the IFN-γ KOs overall displayed altered NE content
within both the locus coeruleus and hippocampus (increased in
the former brain region and reduced in the latter), as well as
diminished hippocampal serotonin turnover. Each of these highly
interconnected, stressor-sensitive brain regions plays a vital role
in memory function, with the hippocampus considered espe-
cially critical for memory consolidation and spatial navigation
(McGaugh, 2000; Suzuki, 2006), and the noradrenergic locus
coeruleus mediating the potent cognition-modulatory effects of
emotional arousal (Gibbs et al., 2010; Sara and Bouret, 2012).
Moreover, human and animal studies alike have implicated both
noradrenergic and serotonergic signaling in the memory pro-
cess, and generally in a facilitatory capacity (Lee and Ma, 1995;
Murchison et al., 2004; Meeter et al., 2006). It seems reasonable
therefore to suggest that dysregulatedmonoaminergic neurotrans-
mission, particularly in the hippocampus, could have been at least
partially responsible for the memory deﬁcit seen in these ani-
mals. Notably, memory impairment may have occurred both in
spite of the observed increase of locus coeruleus NE (e.g., Gibbs
et al., 2010) and independently of dopaminergic neurotransmis-
sion in the nucleus accumbens (which as will be recalled was
unaffected by the experimentalmanipulations). Importantly, since
the KO-speciﬁc hippocampal and locus coeruleus monoamine
changes occurred irrespective of stressor challenge, itwould appear
that IFN-γ normally plays a role in the homeostatic regulation of
these neurotransmitter systems (but presumably not the accum-
bal DA system). Alternatively, as the KOs were without IFN-γ
signal from birth, it is possible that physiological concentra-
tions of the cytokine are required for the normal maturation of
these monoamine systems across development (Litteljohn et al.,
2010).
Of course, such a reading cannot discount the possibility
that other molecular and/or cellular processes might also have
contributed to the presently described memory effects. Indeed,
in our previous work (Litteljohn et al., 2010) we showed that
mice genetically lacking IFN-γ had increased basal corticos-
terone levels and central amygdala monoamine activity, and we
argued that such changes were relevant to the anxious pheno-
type already on record for these animals (Kustova et al., 1998).
Yet, hippocampus-dependent memory is also subject to mod-
ulation by corticosterone and central amygdala monoaminergic
neurotransmission – mainly retrieval in the case of the former
and consolidation as regards the latter (de Quervain et al., 1998;
Hermans et al., 2014) – and it is entirely plausible that one or
both of these processes could have contributed to basal mem-
ory impairment among the IFN-γ KOs. Similarly, as a wealth of
evidence has implicated hippocampal BDNF in memory func-
tion, with a reduction of neurotophin levels generally being
tied to poor memory outcomes and an increase in BDNF levels
usually signaling the opposite (Mizuno et al., 2000; Shirayama
et al., 2002), we had speculated that any IFN-γ KO-associated
decline in memory might also be attended by a reduction in
hippocampal BDNF. Contrary to our expectations, however, it
will be recalled that neither mature nor proBDNF protein lev-
els were affected by IFN-γ deletion. These null BDNF results
are in agreement with the recent enzyme-linked immunosor-
bent assay (ELISA)-based ﬁndings of Campos et al. (2014), and
together our studies provide good evidence that altered hippocam-
pal BDNF does not underlie the neurobehavioral phenotype of
IFN-γ KO mice. That said, our results do not preclude the involve-
ment of BDNF in prospective IFN-γ-associated proactivememory
effects; in fact, Baron et al. (2008) provide evidence that the
memory enhancement seen in mice overexpressing IFN-γ may
at least partially be attributable to an upregulation of central
BDNF.
INFLUENCE OF IFN-γ KNOCKOUT ON MEMORY AND RELATED
NEUROCHEMICAL PROCESSES UNDER CHRONIC STRESSOR
CONDITIONS
If a lack of IFN-γ can under normal conditions be seen to predis-
pose to memory dysfunction, under conditions of chronic stress
the result seems to bememory facilitation. Indeed,whereas neither
the basal state KOs nor the chronically stressed WT mice demon-
strated Y-maze performance that was signiﬁcantly better than
chance, both the stressor-treated IFN-γ-deﬁcient mice and the
non-stressed WT controls displayed intact spatial memory. These
data are aligned somewhat with the ﬁndings of other studies indi-
cating that chronic variable stress can paradoxically (and akin to
what’s been reported for acute as well as predictable chronic stress:
e.g., Parihar et al., 2011; Uysal et al., 2012) enhance memory and
learning (Bartolomucci et al., 2002; McLaughlin et al., 2005; Haw-
ley et al., 2012); here we provide evidence suggesting that IFN-γ,
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or rather a lack thereof, may be key. Interestingly, paralleling the
behavioral data, our neurochemical analyses revealed that nora-
drenergic, but not serotonergic, metabolism was markedly and
selectively augmented in the hippocampus and locus coeruleus
among IFN-γ null mice that were exposed to the chronic stres-
sor. Given the aforementioned importance of these brain regions
in learning and memory (Gibbs et al., 2010), and the generally
facilitative role ascribed to noradrenergic signaling in this regard
(Lee and Ma, 1995), it appears likely that IFN-γ acts to restrict
brain noradrenergic and, consequently, spatial memory responses
to chronic stress.
Recent reports have documented elevations of circulating and
brain IFN-γ levels among rodents exposed to chronic stressors
(Liu et al., 2013; Wrona et al., 2014). And while these ﬁndings
contrast with those of several other animal (e.g., Palumbo et al.,
2012) as well as human studies (Segerstrom and Miller, 2004),
there is a growing recognition that stress hormones can under cer-
tain circumstances augment brain inﬂammation (Sorrells et al.,
2009). A number of routes exist by which IFN-γ could come to
be inﬂuenced by, and hence contribute to, the central actions of
psychological stressors (Litteljohn et al., 2010). One such poten-
tial mechanism involves a stressor-induced shift in the T-helper
type-1 (Th1)/T-helper type-2 (Th2) cytokine balance in favor of
the former (though stressor chronicity is a major inﬂuence here:
Maes et al., 1998; SegerstromandMiller, 2004). In thisway, depres-
sion related pro-inﬂammatory Th1 responses (e.g., IDO activation
and 5-HT depletion), of which IFN-γ is the principal effector,
could become accentuated at the expense of anti-inﬂammatory
Th2 ones (e.g., those mediated by IL-4 and IL-10; Najjar et al.,
2013). Stressors can also provoke intestinal barrier dysfunction
and mucosal inﬂammation (Vicario et al., 2010), which could lead
to not only increased circulating and even central IFN-γ levels
but also the potentiated trafﬁcking of immune cells into the brain
parenchyma (Tran et al., 2000; Schroder et al., 2004). Notably, the
latter could also be realized through a stressor-induced disruption
of blood–brain barrier integrity (Friedman et al., 1996; Northrop
and Yamamoto, 2012). And ﬁnally, that brain-resident microglia
are themselves capable of producing IFN-γ under the direction of
endogenous cytokine signals (i.e., emanating from other glial cells
and not necessarily brain-inﬁltrating leukocytes; Kawanokuchi
et al., 2006) raises the intriguing possibility that stressors could
act directly on microglial cells to inﬂuence central IFN-γ
signaling.
Yet, it should be noted that by the end of the 6-week stres-
sor regimen the chronically stressed KOs also displayed increased
spontaneous locomotor activity; this was evident too in the
stressed WT animals, but seemingly to a lesser degree. Several
studies have linked hyperactivity in rodents to increased brain-
stem and hippocampal noradrenergic activity (though the role of
NE in regulating motor brain circuitry is not straightforward and
almost certainly involves cross-talk with brain DA and 5-HT sys-
tems; Suwabe et al., 2000; Ruocco et al., 2010; Lambertsen et al.,
2012), and there is reason to think that a similar situation could be
relevant to certain clinical contexts – for instance ADHD, impulse
control disorders and (atypical) depression (Viggiano et al., 2004;
Fan et al., 2012). Possibly, then, in the face of ongoing stress a
lack of IFN-γ and the consequent potentiation of noradrenergic
signaling could function as a double-edged sword – at once serv-
ing to facilitate the memory process (Tully and Bolshakov, 2010)
and predisposing to hyperactivity, with the latter perhaps best
viewed as a harbinger of impending allostatic overload. All the
same, it is important to recognize that in the present study the
motor-modulatory effect of stresswas clearly task-speciﬁc. Indeed,
whereas by the end of the 6-week experiment locomotion in the
home-cage was increased among the stressor-exposed mice (pre-
dominantly in the KOs), Y-maze testing only 2 days prior revealed
no such effect of stress (i.e., on total arm entries). Moreover,
it will be recalled that, in the chronically stressed KOs only, Y-
maze performance actually tended to correlate negatively with
total arm entries (retention phase) – a phenomenon that was
revealed elsewhere to be associated with good spatial memory
performance under chronic stressor conditions (Conrad et al.,
2003). Thus, if it can be allowed that enhanced NE utilization
did, in fact, contribute to both the cognitive and home-cage
motor changes observed in the stressed KOs, then these ani-
mals were presumably yet able to harness said noradrenergic drive
to their mnemonic advantage and when the peculiarity of the
circumstances demanded it.
In addition to monoaminergic imbalances, depression and
other stressor-related behavioral disorders may involve distur-
bances of neuroplasticity, including changes in brain structure
and neurotrophin systems (Calabrese et al., 2009; Schmidt and
Duman, 2010; Hayley and Litteljohn, 2013). In particular, circu-
lating levels of BDNF were found to be diminished in depressed
subjects and to correlate with clinical recovery after treatment
initiation (Shimizu et al., 2003; Huang et al., 2008). Similarly, ani-
mal studies revealed that chronic stress often diminishes central
BDNF levels (Murakami et al., 2005; Luo et al., 2013), whereas
BDNF-augmenting strategies (e.g., direct infusions, stimula-
tors) typically induce antidepressant-like behavioral consequences
(Shirayama et al., 2002; Schmidt andDuman,2010;Ye et al., 2011).
We were therefore somewhat surprised to ﬁnd that hippocampal
BDNF remained unchanged in the present study upon expo-
sure to chronic stress. Interestingly, though in the minority, a
number of studies have reported a lack of or even inverse rela-
tionship between hippocampal BDNF and chronic stress (Lucca
et al., 2008; Larsen et al., 2010; Hanson et al., 2011). And while
not contesting the crucial role of BDNF in memory function,
it’s worth noting that hippocampal BDNF has not always been
found to positively correlate with memory performance (Muñoz
et al., 2010; Bechara and Kelly, 2013). Conceivably, then, germline
loss of IFN-γ may have altered the hippocampal neuroinﬂam-
matory milieu in such a way that, in the face of chronic stress,
upregulated (compensatory) expression of alternative growth
factors (e.g., GDNF, NGF, NT-3, IGF-1) and possibly even
anti-inﬂammatory and/or anti-apoptotic messengers (e.g., IL-10
and bcl-2, respectively) could have positively affected memory-
related processes independently of BDNF (Bian et al., 2012;
Xuan et al., 2014).
Alternatively, since chronic stress has been shown to time-
dependently regulate brain regional BDNF expression (Fanous
et al., 2010; Xiao et al., 2011; Lakshminarasimhan and Chattarji,
2012; Capoccia et al., 2013), it is possible that our null BDNF
ﬁndings might be related to the timing of mouse sacriﬁce relative
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to stressor initiation and/or termination. Considering that in the
present study animals were exposed to a rather lengthy 6-week
stressor, a plausible scenario would have the stressor transiently
suppressing BDNF levels, only for them to return to baseline by
the time of sampling. This contention can be seen to derive at
least some support from the home-cage activity data: whereas
locomotor activity was signiﬁcantly elevated after 6 weeks of
exposure to stress (and predominantly in the KOs), at the mid-
way point of the experiment the opposite was, in fact, noted.
In effect, chronic stress time-dependently inﬂuenced home-cage
motor activity and IFN-γ appeared to modulate the magnitude
if not direction of such effects. Without time series data for the
neurochemical endpoints we cannot exclude that hippocampal
BDNF expression similarly changed across time; this is a deﬁnite
weakness of the present study and a suggested worthwhile avenue
of future research. In addition, we cannot speak to any potential
effect of chronic stress or IFN-γ deﬁciency on BDNF expression
at the mRNA level, nor can we rule out the possibility that a
more sensitive assay such as ELISA could have detected presum-
ably very subtle changes in BDNF protein expression. However,
that Campos et al. (2014) failed to demonstrate an effect of IFN-
γ deletion on ELISA-determined BDNF protein levels within the
hippocampus and PFC would seem to lend credence to the present
null ﬁndings, at least in regards to basal state BDNF expression.
And ﬁnally, our use of genetically engineered mice on a C57BL/6J
background might have been an issue, as this mouse strain is con-
sidered to be somewhat less stressor-sensitive than certain other
strains (e.g., BALB/c; Tannenbaum and Anisman, 2003; Poth-
ion et al., 2004). In this regard, Bergström et al. (2008) showed
that chronic mild stress differentially modulates hippocam-
pal BDNF expression in stressor-resilient and stressor-sensitive
rats.
CONCLUSION
To summarize, our data suggest that IFN-γ differentially modu-
latesmemory-related processes under normal and chronic stressor
conditions. Speciﬁcally, in the basal state IFN-γ appears to facil-
itate hippocampus-dependent spatial memory, probably at least
partially due to the cytokine’s involvement in the homeostatic
regulation of relevant brain monoamine systems. Under condi-
tions of chronic stress, however, IFN-γ appears instead to restrict
potentially adaptive brain noradrenergic and spatial memory
responses. While our data do not support a role of hippocampal
BDNF in this regard, they do not preclude the possible involve-
ment of other structural and/or functional neuroplastic processes
(e.g., IFN-γ-dependent alterations of hippocampal neurogene-
sis: Baron et al., 2008; Li et al., 2010; Campos et al., 2014); we
advocate here for further investigation of this intriguing possi-
bility. More generally, the current ﬁndings are aligned with a
growing body of work indicating that stressor context can greatly
inﬂuence the behavioral, immune and neurochemical effects of
other cytokine and immune challenges (e.g., IFN-α, LPS, poly
I:C; Anisman et al., 2007; Gandhi et al., 2007; Gibb et al., 2008).
It should be noted, however, that compensatory neuronal or
immunological changes stemming from a lack of IFN-γ during
key developmental stages could have contributed to the present
ﬁndings.
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